Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000089

CEO bought 10,000 shares at $0.15 ($1,500)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-08-12 Purchase : show line 1 in the form +10,000 $0.15 $1,500 7,147,202 D
Open-market purchases · 10,000 sh · avg $0.15 · $1,500
Loading xslF345X03/primary_doc.xml…